DK4159204T3 - Hidtil ukendt farmaceutisk sammensætning - Google Patents

Hidtil ukendt farmaceutisk sammensætning Download PDF

Info

Publication number: DK4159204T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical composition; hitherto unknown; unknown pharmaceutical; hitherto; composition
Prior art date: 2010-12-20

Application number

DK22209104.3T

Other languages

English (en)

Inventor

Ngocdiep T Le

Francisco Henriquez

Lihong Wang

Marini Douglas J De

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-12-20

Filing date

2011-12-20

Publication date

2024-05-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46314827&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK4159204(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-12-20 Application filed by Novartis Ag filed Critical Novartis Ag

2024-05-21 Application granted granted Critical

2024-05-21 Publication of DK4159204T3 publication Critical patent/DK4159204T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK22209104.3T 2010-12-20 2011-12-20 Hidtil ukendt farmaceutisk sammensætning DK4159204T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201061424967P	2010-12-20	2010-12-20
EP20179788.3A EP3808343A1 (en)	2010-12-20	2011-12-20	Novel pharmaceutical composition

Publications (1)

Publication Number	Publication Date
DK4159204T3 true DK4159204T3 (da)	2024-05-21

Family

ID=46314827

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK11849974.8T DK2654736T3 (da)	2010-12-20	2011-12-20	Hidtil ukendt farmaceutisk sammensætning
DK22209107.6T DK4159205T3 (da)	2010-12-20	2011-12-20	Hidtil ukendt farmaceutisk sammensætning
DK22209104.3T DK4159204T3 (da)	2010-12-20	2011-12-20	Hidtil ukendt farmaceutisk sammensætning

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
DK11849974.8T DK2654736T3 (da)	2010-12-20	2011-12-20	Hidtil ukendt farmaceutisk sammensætning
DK22209107.6T DK4159205T3 (da)	2010-12-20	2011-12-20	Hidtil ukendt farmaceutisk sammensætning

Country Status (38)

Country	Link
US (5)	US8580304B2 (da)
EP (4)	EP4159204B1 (da)
JP (2)	JP6126014B2 (da)
KR (1)	KR101911109B1 (da)
CN (1)	CN103998041B (da)
AR (2)	AR084102A1 (da)
AU (1)	AU2011349422B2 (da)
BR (1)	BR112013015602B1 (da)
CA (1)	CA2822701C (da)
CL (1)	CL2013001779A1 (da)
CR (1)	CR20130352A (da)
CY (1)	CY1123376T1 (da)
DK (3)	DK2654736T3 (da)
DO (1)	DOP2013000138A (da)
EA (1)	EA025198B1 (da)
ES (3)	ES2982775T3 (da)
FI (2)	FI4159205T3 (da)
HR (3)	HRP20240563T1 (da)
HU (3)	HUE050788T2 (da)
IL (1)	IL226855A (da)
JO (1)	JO3594B1 (da)
LT (3)	LT4159205T (da)
MA (1)	MA34883B1 (da)
MX (1)	MX2013007073A (da)
MY (1)	MY170501A (da)
NZ (1)	NZ612157A (da)
PE (1)	PE20140040A1 (da)
PH (1)	PH12013501209A1 (da)
PL (3)	PL2654736T3 (da)
PT (3)	PT4159204T (da)
RS (2)	RS65497B1 (da)
SG (1)	SG191054A1 (da)
SI (3)	SI4159205T1 (da)
TW (1)	TWI505828B (da)
UA (1)	UA113158C2 (da)
UY (1)	UY33818A (da)
WO (1)	WO2012088033A2 (da)
ZA (1)	ZA201304189B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI505828B (zh)	2010-12-20	2015-11-01	葛蘭素史克智慧財產（第二）有限公司	新穎醫藥組成物
KR20190057421A (ko)	2012-08-17	2019-05-28	에프. 호프만-라 로슈 아게	코비메티닙 및 베무라피닙을 투여함을 포함하는 흑색종의 조합 치료법
CN104902876B (zh) *	2012-11-30	2018-01-19	葛兰素史克公司	新型药物组合物
WO2015019125A1 (en) *	2013-08-05	2015-02-12	Societe De Developpement Et De Recherche Industrielle	Molecular targets for the treatment of wounds, in particular chronic wounds
CN103819471A (zh) *	2013-11-25	2014-05-28	镇江圣安医药有限公司	吡啶并(4,3-d)嘧啶-1（2H）-基苯基乙酰胺的衍生物及其应用
WO2015081566A1 (zh) *	2013-12-06	2015-06-11	杭州普晒医药科技有限公司	曲美替尼及其溶剂化物的晶型、其制备方法、含有它们的药物组合物及其用途
EP2913048A1 (en) *	2014-02-27	2015-09-02	ratiopharm GmbH	Pharmaceutical composition comprising trametinib
WO2016126012A1 (en) *	2015-02-05	2016-08-11	Boryung Pharmaceutical Co., Ltd	Tablet and method of preparing the same
KR101545268B1 (ko)	2015-02-05	2015-08-20	보령제약 주식회사	정제 및 이의 제조방법
US20170020880A1 (en) *	2015-07-22	2017-01-26	Hetero Research Foundation	Pharmaceutical compositions of trametinib
TWI855386B (zh) *	2016-08-10	2024-09-11	瑞士商赫孚孟拉羅股份公司	包含Ａｋｔ蛋白質激酶抑制劑之醫藥組合物
RU2627692C1 (ru)	2016-10-10	2017-08-10	Закрытое акционерное общество "Р-Фарм" (ЗАО "Р-Фарм")	N-{ 3-[3-циклопропил-5-(2-фторо-4-иодофениламино)-6,8-диметил-2,4,7-триоксо-3,4,6,7-тетрагидро-2Н-пиридо[4,3-d]пиримидин-1-ил]-фенил} -циклопропанкарбоксамида диметилсульфоксида сольват в качестве ингибитора МЕК1/2
CN108778281B (zh)	2016-11-25	2021-09-03	江苏恒瑞医药股份有限公司	一种吡啶酮类衍生物药物组合物及其制备方法
CA3057969A1 (en)	2017-05-02	2018-11-08	Novartis Ag	Combination therapy
KR20220008273A (ko)	2019-05-13	2022-01-20	노파르티스 아게	암 치료를 위한 raf 억제제로서의 n-(3-(2-(2-하이드록시에톡시)-6-모르폴리노피리딘-4-일)-4-메틸페닐)-2 (트리플루오로메틸)이소니코틴아미드의 새로운 결정질 형태
CN114340670A (zh)	2019-07-11	2022-04-12	普拉克西斯精密药物股份有限公司	T-型钙通道调节剂的制剂及其使用方法
EP4007585A4 (en)	2019-08-02	2023-11-08	OneHealthCompany, Inc.	TREATMENT OF CANCER IN DOGS
RU2749719C1 (ru) *	2020-10-08	2021-06-16	Нестерук Владимир Викторович	Препарат для лечения анемии, связанной с хроническим заболеванием почек, и способ его получения
WO2023105286A1 (en)	2021-12-06	2023-06-15	My Personal Therapeutics Ltd	A combination treatment for cancer
WO2024171019A1 (en) *	2023-02-13	2024-08-22	Alembic Pharmaceuticals Limited	Pharmaceutical composition of trametinib and process of preparation thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61205257A (ja) *	1985-03-08	1986-09-11	Ishihara Sangyo Kaisha Ltd	ベンゾイルウレア系化合物、その製法及びそれを含有する抗ガン剤
US4727077A (en)	1985-02-20	1988-02-23	Ishihara Sangyo Kaisha Ltd.	Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
US5559235A (en)	1991-10-29	1996-09-24	Glaxo Wellcome Inc.	Water soluble camptothecin derivatives
US5342947A (en)	1992-10-09	1994-08-30	Glaxo Inc.	Preparation of water soluble camptothecin derivatives
US5681835A (en)	1994-04-25	1997-10-28	Glaxo Wellcome Inc.	Non-steroidal ligands for the estrogen receptor
US5491237A (en)	1994-05-03	1996-02-13	Glaxo Wellcome Inc.	Intermediates in pharmaceutical camptothecin preparation
GB9716557D0 (en)	1997-08-06	1997-10-08	Glaxo Group Ltd	Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity
US6825180B2 (en)	2001-05-18	2004-11-30	Cell Therapeutics, Inc.	Pyridopyrimidine compounds and their uses
US7378423B2 (en) *	2004-06-11	2008-05-27	Japan Tobacco Inc.	Pyrimidine compound and medical use thereof
ATE383360T1 (de)	2004-06-11	2008-01-15	Japan Tobacco Inc	5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h- pyrido(2,3-d)pyrimidinderivate und verwandte verbindungen zur behandlung von krebs
WO2008048469A2 (en) *	2006-10-13	2008-04-24	Actavis Group Pct Hf	Controlled-release coated dosage forms containing galantamine
EP2086518A2 (en) *	2006-11-09	2009-08-12	Gilead Colorado, Inc.	Darusentan oral dosage form
JO2985B1 (ar) *	2006-12-20	2016-09-05	Takeda Pharmaceuticals Co	مثبطات كينازmapk/erk
UY30892A1 (es)	2007-02-07	2008-09-02	Smithkline Beckman Corp	Inhibidores de la actividad akt
ECSP077628A (es)	2007-05-03	2008-12-30	Smithkline Beechman Corp	Nueva composición farmacéutica
CA2924436A1 (en) *	2007-07-30	2009-02-05	Ardea Biosciences, Inc.	Pharmaceutical combinations of n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide as inhibitors of mek and methods of use
WO2009042809A1 (en) *	2007-09-25	2009-04-02	Teva Pharmaceutical Industries Ltd.	Stable imatinib compositions
UA103319C2 (en)	2008-05-06	2013-10-10	Глаксосмитклайн Ллк	Thiazole- and oxazole-benzene sulfonamide compounds
CA2730311A1 (en)	2008-07-08	2010-01-14	Beta Pharma Inc.	Icotinib hydrochloride, synthesis, crystalline forms, drug combinations, and uses thereof
EP2480084B1 (en)	2009-09-23	2014-11-12	GlaxoSmithKline LLC	Pharmaceutical combination
CA2775125C (en)	2009-09-23	2019-01-08	Glaxosmithkline Llc	Combination of a mek inhibitor and an akt inhibitor to treat cancer
CN102665719A (zh) *	2009-09-28	2012-09-12	葛兰素史密斯克莱有限责任公司	组合
US8703781B2 (en) *	2009-10-16	2014-04-22	Glaxosmithkline Llc	Pharmaceutical combination of MEK inhibitor and B-RAF inhibitors
BR112012011677A8 (pt)	2009-11-17	2018-06-12	Glaxosmithkline Llc	Combinação, kit de combinação e uso de uma combinação
JP5903433B2 (ja)	2010-08-26	2016-04-13	ノバルティスアーゲー	癌の治療に有用なｖｅｇｆｒ阻害剤およびｍｅｋ阻害剤の医薬的組み合わせ
TWI505828B (zh)	2010-12-20	2015-11-01	葛蘭素史克智慧財產（第二）有限公司	新穎醫藥組成物
US8977217B1 (en)	2013-02-20	2015-03-10	Triquint Semiconductor, Inc.	Switching device with negative bias circuit

2011
- 2011-12-16 TW TW100146692A patent/TWI505828B/zh active
- 2011-12-18 JO JOP/2011/0385A patent/JO3594B1/ar active
- 2011-12-19 AR ARP110104773A patent/AR084102A1/es not_active Application Discontinuation
- 2011-12-19 UY UY0001033818A patent/UY33818A/es active IP Right Grant
- 2011-12-20 SI SI201132108T patent/SI4159205T1/sl unknown
- 2011-12-20 RS RS20240519A patent/RS65497B1/sr unknown
- 2011-12-20 US US13/330,949 patent/US8580304B2/en active Active
- 2011-12-20 AU AU2011349422A patent/AU2011349422B2/en active Active
- 2011-12-20 RS RS20240518A patent/RS65496B1/sr unknown
- 2011-12-20 CN CN201180066851.0A patent/CN103998041B/zh active Active
- 2011-12-20 FI FIEP22209107.6T patent/FI4159205T3/fi active
- 2011-12-20 JP JP2013546310A patent/JP6126014B2/ja active Active
- 2011-12-20 LT LTEP22209107.6T patent/LT4159205T/lt unknown
- 2011-12-20 EP EP22209104.3A patent/EP4159204B1/en active Active
- 2011-12-20 SG SG2013044037A patent/SG191054A1/en unknown
- 2011-12-20 PH PH1/2013/501209A patent/PH12013501209A1/en unknown
- 2011-12-20 PE PE2013001442A patent/PE20140040A1/es active IP Right Grant
- 2011-12-20 ES ES22209104T patent/ES2982775T3/es active Active
- 2011-12-20 CA CA2822701A patent/CA2822701C/en active Active
- 2011-12-20 EP EP11849974.8A patent/EP2654736B1/en active Active
- 2011-12-20 MY MYPI2013701038A patent/MY170501A/en unknown
- 2011-12-20 FI FIEP22209104.3T patent/FI4159204T3/fi active
- 2011-12-20 ES ES22209107T patent/ES2985024T3/es active Active
- 2011-12-20 MX MX2013007073A patent/MX2013007073A/es active IP Right Grant
- 2011-12-20 PL PL11849974T patent/PL2654736T3/pl unknown
- 2011-12-20 DK DK11849974.8T patent/DK2654736T3/da active
- 2011-12-20 ES ES11849974T patent/ES2820536T3/es active Active
- 2011-12-20 SI SI201132109T patent/SI4159204T1/sl unknown
- 2011-12-20 WO PCT/US2011/066021 patent/WO2012088033A2/en active Application Filing
- 2011-12-20 BR BR112013015602-3A patent/BR112013015602B1/pt active IP Right Grant
- 2011-12-20 HR HRP20240563TT patent/HRP20240563T1/hr unknown
- 2011-12-20 KR KR1020137019029A patent/KR101911109B1/ko active IP Right Grant
- 2011-12-20 LT LTEP11849974.8T patent/LT2654736T/lt unknown
- 2011-12-20 DK DK22209107.6T patent/DK4159205T3/da active
- 2011-12-20 PT PT222091043T patent/PT4159204T/pt unknown
- 2011-12-20 UA UAA201309128A patent/UA113158C2/uk unknown
- 2011-12-20 PL PL22209104.3T patent/PL4159204T3/pl unknown
- 2011-12-20 NZ NZ612157A patent/NZ612157A/en unknown
- 2011-12-20 PT PT222091076T patent/PT4159205T/pt unknown
- 2011-12-20 PT PT118499748T patent/PT2654736T/pt unknown
- 2011-12-20 HU HUE11849974A patent/HUE050788T2/hu unknown
- 2011-12-20 US US13/991,705 patent/US20130266649A1/en not_active Abandoned
- 2011-12-20 SI SI201131918T patent/SI2654736T1/sl unknown
- 2011-12-20 DK DK22209104.3T patent/DK4159204T3/da active
- 2011-12-20 HR HRP20240564TT patent/HRP20240564T1/hr unknown
- 2011-12-20 HU HUE22209104A patent/HUE066525T2/hu unknown
- 2011-12-20 HU HUE22209107A patent/HUE066526T2/hu unknown
- 2011-12-20 PL PL22209107.6T patent/PL4159205T3/pl unknown
- 2011-12-20 MA MA36106A patent/MA34883B1/fr unknown
- 2011-12-20 EA EA201390913A patent/EA025198B1/ru not_active IP Right Cessation
- 2011-12-20 LT LTEP22209104.3T patent/LT4159204T/lt unknown
- 2011-12-20 EP EP20179788.3A patent/EP3808343A1/en active Pending
- 2011-12-20 EP EP22209107.6A patent/EP4159205B1/en active Active
2013
- 2013-06-07 ZA ZA2013/04189A patent/ZA201304189B/en unknown
- 2013-06-10 IL IL226855A patent/IL226855A/en active IP Right Grant
- 2013-06-18 CL CL2013001779A patent/CL2013001779A1/es unknown
- 2013-06-18 DO DO2013000138A patent/DOP2013000138A/es unknown
- 2013-07-19 CR CR20130352A patent/CR20130352A/es unknown
- 2013-10-02 US US14/044,139 patent/US9271941B2/en active Active
- 2013-12-11 US US14/103,193 patent/US9155706B2/en active Active
- 2013-12-11 US US14/103,092 patent/US9399021B2/en active Active
2017
- 2017-01-19 JP JP2017007796A patent/JP2017137299A/ja not_active Withdrawn
2020
- 2020-09-03 HR HRP20201409TT patent/HRP20201409T1/hr unknown
- 2020-09-24 CY CY20201100905T patent/CY1123376T1/el unknown
2021
- 2021-05-27 AR ARP210101433A patent/AR122185A2/es unknown

Also Published As

Publication number	Publication date
JP2014510704A (ja)	2014-05-01
ES2982775T3 (es)	2024-10-17
MX2013007073A (es)	2013-09-26
JP6126014B2 (ja)	2017-05-10
CL2013001779A1 (es)	2014-06-27
EP4159205B1 (en)	2024-02-14
CN103998041A (zh)	2014-08-20
WO2012088033A3 (en)	2014-03-13
HRP20201409T1 (hr)	2020-11-27
PT2654736T (pt)	2020-09-24
LT4159205T (lt)	2024-05-10
EA201390913A1 (ru)	2014-04-30
US20130266649A1 (en)	2013-10-10
PH12013501209A1 (en)	2013-07-29
PL4159204T3 (pl)	2024-07-01
EP4159204A1 (en)	2023-04-05
ES2985024T3 (es)	2024-11-04
EP4159204B1 (en)	2024-02-14
SI2654736T1 (sl)	2020-10-30
FI4159205T3 (fi)	2024-04-23
MY170501A (en)	2019-08-08
US9155706B2 (en)	2015-10-13
RS65496B1 (sr)	2024-06-28
US9271941B2 (en)	2016-03-01
IL226855A (en)	2017-04-30
RS65497B1 (sr)	2024-06-28
EP2654736A2 (en)	2013-10-30
HUE050788T2 (hu)	2021-01-28
TWI505828B (zh)	2015-11-01
LT4159204T (lt)	2024-05-10
PE20140040A1 (es)	2014-02-26
US20120183613A1 (en)	2012-07-19
HUE066525T2 (hu)	2024-08-28
US8580304B2 (en)	2013-11-12
US20140037726A1 (en)	2014-02-06
SG191054A1 (en)	2013-08-30
AR122185A2 (es)	2022-08-24
PT4159205T (pt)	2024-05-08
ES2820536T3 (es)	2021-04-21
HUE066526T2 (hu)	2024-08-28
DK4159205T3 (da)	2024-05-13
BR112013015602B1 (pt)	2022-03-03
EA025198B1 (ru)	2016-11-30
KR101911109B1 (ko)	2018-10-23
LT2654736T (lt)	2020-09-25
DK2654736T3 (da)	2020-09-14
DOP2013000138A (es)	2013-11-30
CR20130352A (es)	2013-12-18
AR084102A1 (es)	2013-04-24
US9399021B2 (en)	2016-07-26
JO3594B1 (ar)	2020-07-05
UA113158C2 (xx)	2016-12-26
JP2017137299A (ja)	2017-08-10
WO2012088033A2 (en)	2012-06-28
PT4159204T (pt)	2024-05-07
EP2654736A4 (en)	2015-04-22
ZA201304189B (en)	2014-02-26
CN103998041B (zh)	2016-08-17
US20140099365A1 (en)	2014-04-10
NZ612157A (en)	2015-05-29
CA2822701A1 (en)	2012-06-28
HRP20240563T1 (hr)	2024-08-16
CY1123376T1 (el)	2021-12-31
US20140154316A1 (en)	2014-06-05
AU2011349422B2 (en)	2015-12-10
EP3808343A1 (en)	2021-04-21
AU2011349422A1 (en)	2013-05-02
KR20130130028A (ko)	2013-11-29
CA2822701C (en)	2018-10-23
MA34883B1 (fr)	2014-02-01
BR112013015602A2 (pt)	2017-02-21
SI4159205T1 (sl)	2024-06-28
FI4159204T3 (fi)	2024-04-22
SI4159204T1 (sl)	2024-06-28
UY33818A (es)	2012-07-31
TW201249441A (en)	2012-12-16
PL2654736T3 (pl)	2020-12-14
EP2654736B1 (en)	2020-07-01
EP4159205A1 (en)	2023-04-05
HRP20240564T1 (hr)	2024-09-27
PL4159205T3 (pl)	2024-06-24

Publication	Publication Date	Title
HRP20191852T8 (hr)	2021-10-01	Polipeptidi
DK4159204T3 (da)	2024-05-21	Hidtil ukendt farmaceutisk sammensætning
SMT201700008B (it)	2017-03-08	Composizione farmaceutica
SMT201600350B (it)	2016-11-10	Composizioni farmaceutiche
IL245328A0 (en)	2016-06-30	Pharmaceutical composition
DK2694038T3 (da)	2019-08-19	Farmaceutisk sammensætning
DK3053932T3 (da)	2020-10-19	Hidtil ukendte ctla4-ig-immunoadhesiner
BR112014003052A2 (pt)	2017-03-01	composições farmacêuticas
SMT201400069B (it)	2014-07-07	Formulazione farmaceutica
DK2590974T3 (da)	2014-07-28	Tetrahydropyridopyrimidinderivater
CO6930367A2 (es)	2014-04-28	Composiciones farmaceúticas
EE201300005A (et)	2013-08-15	Ravimkoostis
BR112013011042A2 (pt)	2016-08-23	dispensador
GT201200303A (es)	2014-04-29	Formulaciones farmacéuticas
HUE040370T2 (hu)	2019-03-28	Gyógyszerkészítmények
DK2815752T3 (da)	2020-07-20	Oral farmaceutisk sammensætning
BR112013008074A2 (pt)	2016-06-14	combinações farmacêuticas
CO6801722A2 (es)	2013-11-29	Composiciones farmacéuticas
BR112014009319A2 (pt)	2017-05-30	compostos farmacêuticos
BR112012022411A2 (pt)	2016-07-05	articulador
EP2769718A4 (en)	2015-07-01	MEDICAL COMPOSITION
DK2553004T3 (da)	2019-09-16	Sammensatte materialer
FI20105941A0 (fi)	2010-09-11	Kipsausmateriaalit
BR112013014951A2 (pt)	2016-09-13	selos
BR112012029461A2 (pt)	2017-03-01	composição farmacêutica contendo solifenacina